Reply to 'Methicillin-resistant Staphylococcus Aureus'

E. Vanderhelst, Linda De Meirleir, Sylvia Verbanck, Denis Pierard, Walter Vincken, Anne Malfroot

Research output: Contribution to journalLetter

1 Citation (Scopus)


Turner et al. [1] raise an important and timely issue about the management of CF patients suffering chronic infection with methicillin-resistant Staphylococcus aureus (MRSA), given that the prevalence of MRSA in respiratory cultures of CF patients has increased over the past decade. In our study [2], the prevalence of chronic MRSA colonization in the CF Center of the University Hospital of Brussels was 12.6%. Our spirometric data showed that a MRSA episode entailed an FEV1 decline that was almost double that predicted for CF patients who could remain unaffected by MRSA.
Original languageEnglish
Pages (from-to)183-183
Number of pages1
JournalJournal of Cystic Fibrosis
Issue number2
Publication statusPublished - Mar 2013


  • Respiratory System
  • Cystic-fibrosis


Dive into the research topics of 'Reply to 'Methicillin-resistant Staphylococcus Aureus''. Together they form a unique fingerprint.

Cite this